Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute (Q43629476)

25 November 2017

title

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute (English)

1 reference

25 November 2017

1 reference

1 reference

Jeung HC

1

1 reference

25 November 2017

Rha SY

2

1 reference

25 November 2017

Noh SH

3

1 reference

25 November 2017

Min JS

4

1 reference

25 November 2017

Kim BS

5

1 reference

25 November 2017

Chung HC

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

91

1 reference

25 November 2017

issue

11

1 reference

25 November 2017

page(s)

2016-2025

1 reference

Adjuvant treatment in gastric cancer

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Review of adjuvant chemotherapy for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Current status of chemotherapy for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

The role of anthracyclines in the treatment of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Adjuvant treatment of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Mitomycin C as an adjuvant in resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Treatment of advanced gastric cancer with 5-fluorouracil versus mitomycin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010601%2991%3A11%3C2016%3A%3AAID-CNCR1227%3E3.0.CO%3B2-I

10.1002/1097-0142(20010601)91:11<2016::AID-CNCR1227>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference